Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
ISRADIPINE
臺灣諾華股份有限公司 台北市中正區仁愛路二段99號11、12、13樓 (01516589)
C08CA03
持續性藥效膠囊劑
ISRADIPINE (2412402100) 2.5MG
盒裝
製 劑
須由醫師處方使用
NOVARTIS FARMACEUTICA S.A. RONDA SANTA MARIA,158,08210 BARBERA DEL VALLES BARCELONA,SPAIN ES
isradipine
高血壓
註銷日期: 2016/02/15; 註銷理由: 自請註銷; 有效日期: 2016/08/02; 英文品名: DYNACIRC SRO CAPSULES 2.5MG
已註銷
1996-08-02
DYNACIRC SRO Selective calcium channel blockers with mainly vascular effects, dihydropyridine derivatives. DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORMS 2.5 mg and 5 mg modified release capsules (SRO capsules) for oral administration. ACTIVE SUBSTANCE Isradipine Certain dosage strengths and dosage forms may not be available in all countries. EXCIPIENTS DYNACIRC 2.5 MG SRO CAPSULES: Cellulose, microcrystalline; cetyl palmitate; gelatine; iron oxide, black (only for Dynacirc 2.5 mg SRO); iron oxide, yellow; magnesium stearate; hypromellose shellac; silica, colloidal anhydrous; titanium dioxide. DYNACIRC 5 MG SRO CAPSULES: Cellulose, microcrystalline; cetyl palmitate; gelatine; iron oxide, red (only for Dynacirc 5 mg SRO); iron oxide, yellow; magnesium stearate; hypromellose shellac; silica, colloidal anhydrous; titanium dioxide. INDICATIONS Treatment of hypertension. DOSAGE AND ADMINISTRATION DYNACIRC SRO CAPSULES 2.5MG The recommended dosage in mild to moderate hypertension is 2.5 mg (one tablet) twice a day or one 5 mg SRO capsule once a day. DYNACIRC SRO CAPSULES 5MG The recommended dosage in mild to moderate hypertension is one 5 mg SRO capsule once a day. Dynacirc SRO capsules must be swallowed whole. If one 5 mg SRO capsule once a day is not sufficiently effective, after at least 4 weeks of treatment, the addition of another antihypertensive agent is recommended (preferably a thiazide diuretic, ACE inhibitor or beta-blocker). Dynacirc SRO can also be added to existing antihypertensive treatment. When Dynacirc SRO is given concurrently with cimetidine, the dose of Dynacirc / Dynacirc SRO should be reduced by 50% (see section INTERACTIONS). SPECIAL POPULATIONS Geriatrics, renal impairment and hepatic impairmentIn elderly patients or in patients with impaired hepatic or renal function, a more suitable starting dose is 1.25 mg (½ tablet) twice a day or one 2.5 mg SRO capsule once a day. Pediatrics Well designed clinical trials of calcium channel blockers in children have not been performed. Although limit Read the complete document